Add BrightSurf on Google Email

To heal skin, scientists invent living bioelectronics

Researchers at Rutgers University have developed a unique prototype of a 'living bioelectronic' device that combines advanced electronics, living cells, and hydrogel to treat psoriasis. The patch continuously monitors skin conditions and provides real-time feedback, offering a potential treatment for psoriasis and other skin ailments.

SourceRutgers University·JournalScience·TypeObservational study·DateJun 12, 2024

Treating rare skin diseases by transplanting healthy skin

Researchers from Nagoya University have successfully treated rare genetic skin disorders epidermolytic ichthyosis (EI) and ichthyosis with confetti (IWC) by transplanting genetically healthy skin to inflamed areas. Transplantation of healthy skin has been used as a treatment option for severe burn injuries.

SourceNagoya University·JournalBritish Journal of Dermatology·DateJun 10, 2024

Mosaics of predisposition cause skin disease

Researchers at Kobe University discovered a new gene, FDFT1, responsible for porokeratosis by identifying epigenetic silencing. Patients with localized lesions didn't have inherited damaged copies, leading to a hypothesis that epigenetic changes are the first hit. The findings have implications for treatment and counseling.

SourceKobe University·JournalThe American Journal of Human Genetics·TypeObservational study·DateApr 22, 2024

New study maps a group of rare genetic diseases for the first time

A new study from Aarhus University reveals that only 67% of Danes registered with an ectodermal dysplasia diagnosis actually have congenital ectodermal dysplasia. The study identifies key characteristics, including abnormal teeth, skin issues, and nail problems, highlighting the need for collaboration across healthcare disciplines.

SourceAarhus University·JournalJAMA Dermatology·TypeSystematic review·DateApr 2, 2024

New insights revealed on tissue-dependent roles of JAK signaling in inflammation

Researchers have gained a deeper understanding of the nuanced roles of JAK inhibitors in inflammation across various cell types and tissues. The study reveals that activating JAK1 signaling has tissue-specific effects, including an unexpected immunoregulatory role in lung sensory neurons, which suppresses lung inflammation.

Not all itches are the same, according to the brain

Researchers at Salk Institute discover that mechanical and chemical itch sensations are encoded by different brain pathways, which act together to drive chronic itch. The study reveals key molecules regulating these pathways and opens avenues for new therapies.

SourceSalk Institute·JournalNeuron·TypeExperimental study·DateApr 5, 2023

New study: abatacept therapy offers promising results treating juvenile dermatomyositis

A new study published in Arthritis & Rheumatology reports significant improvements in disease activity for patients with refractory juvenile dermatomyositis treated with abatacept therapy. The randomized controlled trial demonstrates the potential of abatacept as a treatment option for this rare and debilitating condition.

SourceGeorge Washington University·JournalArthritis & Rheumatology·TypeRandomized controlled/clinical trial·DateMar 8, 2023

ProDERM study results of Octagam® 10% treatment in patients with dermatomyositis published in the New England Journal of Medicine

A large randomized clinical trial demonstrated Octagam 10% as an efficacious and well-tolerated treatment option for adult dermatomyositis patients. The study showed improved outcomes in patients with this rare disease, providing a much-needed treatment alternative.

SourceYankee Public Relations·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 6, 2022

Lenabasum, a cannabinoid receptor agonist, is an effective and safe treatment for amyopathic dermatomyositis

Lenabasum has been shown to improve skin symptoms in patients with amyopathic dermatomyositis, demonstrating significant reductions in inflammation and disease severity. The study's findings suggest that lenabasum is a well-tolerated treatment option for refractory skin disease.

SourceElsevier·JournalJournal of Investigative Dermatology·TypeRandomized controlled/clinical trial·DateSep 21, 2022

Mechanistic insights into contact hypersensitivity could pave the way for drug discovery

A study by Japanese researchers from Fujita Health University sheds light on the molecular mechanisms of contact dermatitis, revealing that neutrophil extracellular traps play a key role in the condition. The team's findings suggest that inhibiting NET formation could be a new therapeutic strategy for treating contact dermatitis.

SourceFujita Health University·JournalScientific Reports·TypeExperimental study·DateAug 17, 2022

Microbiota medicine: towards clinical revolution

A recent report by the International Society of Microbiota confirms a bidirectional interplay between gut microbiota and various organs, highlighting the crucial role of microbiota in disease pathogenesis. The report also explores therapeutic strategies for manipulating gut microbiota to prevent and treat disorders.

SourceMitochondria-Microbiota Task Force·JournalJournal of Translational Medicine·TypeSystematic review·DateMar 31, 2022

Predicting heart disease from the skin

A study published in Scientific Reports reveals that mutations in a gene underlying a rare skin disorder can also lead to arrhythmogenic right ventricular cardiomyopathy, a serious heart disease. The findings indicate that the genetic underpinnings of skin disorders at birth may help predict future heart problems.

SourceThomas Jefferson University·JournalScientific Reports·DateDec 10, 2020

The Mona Lisa decrypted

Dr. Mandeep R. Mehra proposes a novel explanation for the Mona Lisa's smile and facial features, attributing them to clinical hypothyroidism. The theory is supported by visible signs of thyroid dysfunction in the painting, including thinning hair and yellow skin.

SourceBrigham and Women's Hospital·JournalMayo Clinic Proceedings·DateSep 4, 2018

60 genetic disorders affect skin and nervous system

Researchers from Loyola University Medical Center identified 60 genetic diseases that involve the skin, central nervous system, and/or peripheral nervous system. These conditions, including neurofibromatosis, can cause a range of symptoms such as tumors, learning disabilities, and bone deformities.

SourceLoyola Medicine·JournalCurrent Neurology and Neuroscience Reports·DateJan 21, 2016